Alrex
Company: Bausch & Lomb, Pharmos
Approval Status: Approved March 1998
Treatment for: seasonal allergic conjunctivitis
Areas: Ophthalmology
General Information
Other Useful Resources
Alrex is indicated for the treatment of seasonal allergic conjunctivitis, an inflammation of the eye usually caused by pollens. Seasonal allergic conjunctivitis produces itching, tearing, redness, and swelling in the membrane that covers the inside of the eyelid and the white part of the eye.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
Medical Dictionary Searches
